Filter Results:
(422)
Show Results For
- All HBS Web
(1,060)
- People (7)
- News (417)
- Research (422)
- Multimedia (8)
- Faculty Publications (116)
Show Results For
- All HBS Web
(1,060)
- People (7)
- News (417)
- Research (422)
- Multimedia (8)
- Faculty Publications (116)
Sort by
- October 2022
- Supplement
The SAH Group: The Time is Right, Instructor Spreadsheet
By: Juan Alcacer and Alpana Thapar
In January 2021, Jalila Mezni, CEO of the SAH Group, was preparing to present the company’s future growth plans to its board of directors. The Tunisian company was a leading producer and distributor of personal care and packaged hygiene products. In 2019, it expanded... View Details
Keywords: Growth Strategy; Entrepreneurship; Investment Decisions; Growth Management; Vertical Integration; Distribution; Competition; Strategy; Supply Chain; Presentations; Product Positioning; Market Entry and Exit; Pulp and Paper Industry; Pulp and Paper Industry; Pulp and Paper Industry; Tunisia
- 29 May 2001
- Research & Ideas
How Technological Disruption Changes Everything
the fundamental causal mechanisms through which our lives have improved," Christensen said. Health Care Takes A Hit At the conference, Christensen looked forward to areas where disruptive technologies... View Details
- 10 Apr 2018
- First Look
First Look at New Research, April 10, 2018
https://www.hbs.edu/faculty/Pages/item.aspx?num=54331 forthcoming American Economic Journal: Economic Policy Physician Beliefs and Patient Preferences: A New Look at Regional Variation in Health View Details
Keywords: Sean Silverthorne
- November 2017
- Article
A Retrospective Analysis of Hypertension Screening at a Mass Gathering in India: Implications for Non-communicable Disease Control Strategies
By: S. Balsari, P. Vemulapalli, M. Gofine, K. Oswal, R. Merchant, S. Saunik, G. Greenough and T. Khanna
Cardiovascular disease is the leading cause of mortality from noncommunicable diseases (NCD) in India. The government’s National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases and Stroke seeks to increase capacity building, screening,... View Details
Balsari, S., P. Vemulapalli, M. Gofine, K. Oswal, R. Merchant, S. Saunik, G. Greenough, and T. Khanna. "A Retrospective Analysis of Hypertension Screening at a Mass Gathering in India: Implications for Non-communicable Disease Control Strategies." Journal of Human Hypertension 31, no. 11 (November 2017): 750–753.
- Forthcoming
- Book
How to Be Bold: The Surprising Science of Everyday Courage
By: Ranjay Gulati
What leads people to speak truth to power, share bold new ideas, or put their lives on the line? Most of us chalk it up to personality, presuming that our heroes are naturally fearless. But what if courage isn’t simply a matter of personality? What if it’s something... View Details
Gulati, Ranjay. How to Be Bold: The Surprising Science of Everyday Courage. HarperCollins, forthcoming.
- May 2024 (Revised February 2025)
- Case
Choosing the Course of Passion: Brooke Boyarsky Pratt at knownwell
By: Jon M. Jachimowicz and Alexis Lefort
Brooke Boyarsky Pratt (HBS ’13) enjoyed considerable success in her early career, quickly climbing the ranks to associate partner at McKinsey, and later becoming an executive vice president at Berkadia, a Berkshire Hathaway portfolio company. Throughout these years,... View Details
Keywords: Passion; Career; Career Planning; Purpose; Personal Development and Career; Mission and Purpose; Identity; Business Startups; Health Care and Treatment; Health Disorders; Growth and Development Strategy; Market Entry and Exit; Health Industry; United States
Jachimowicz, Jon M., and Alexis Lefort. "Choosing the Course of Passion: Brooke Boyarsky Pratt at knownwell." Harvard Business School Case 424-040, May 2024. (Revised February 2025.)
- May 2021
- Supplement
Paul Levy: Confronting a 'Corporate Campaign' (B)
By: James K. Sebenius and Isaac Silberberg
Paul Levy, CEO of the Beth Israel Deaconess Medical Center hospital is faced with a formidable negotiation campaign to unionize staff at BIDMC. Armed only with his personal blog, does Paul stand a chance against the union's multi-million dollar organizing budget? View Details
- December 2005 (Revised August 2006)
- Case
Amgen Inc.'s Epogen--Commercializing the First Biotech Blockbuster Drug
By: Felix Oberholzer-Gee and Dennis A. Yao
Amgen Inc.'s Epogen was the first biotech blockbuster drug. Epogen helped prevent anemia, a condition that leads to severe fatigue, increased risk of cardiovascular disease, and even death. At the time, the market for Epogen, which included dialysis patients and... View Details
Keywords: Health Care and Treatment; Strategic Planning; Competition; Patents; Innovation and Invention; Pharmaceutical Industry; Biotechnology Industry; United States
Oberholzer-Gee, Felix, and Dennis A. Yao. "Amgen Inc.'s Epogen--Commercializing the First Biotech Blockbuster Drug." Harvard Business School Case 706-454, December 2005. (Revised August 2006.)
- 19 May 2015
- First Look
First Look: May 19
surrounding growth of a nonprofit institution and the United Kingdom's socialized health care system. Purchase this case:... View Details
Keywords: Sean Silverthorne
- 26 Mar 2014
- Research & Ideas
How Electronic Patient Records Can Slow Doctor Productivity
Digital Doctor In recent years, many physicians have put away pen-and-paper and taken up the keyboard or tablet to maintain patient health records. One motivation was the 2009 View Details
- January 2014 (Revised December 2014)
- Case
GenapSys: Business Models for the Genome
By: Richard G. Hamermesh, Joseph B. Fuller and Matthew Preble
GenapSys, a California-based startup, was soon to release a new DNA sequencer that the company's founder, Hesaam Esfandyarpour, believed was truly revolutionary. The sequencer would be substantially less expensive—potentially costing just a few thousand dollars—and... View Details
Keywords: DNA Sequencing; Life Sciences; Business Model; Innovation & Entrepreneurship; Health Care and Treatment; Genetics; Business Strategy; Health Industry; Health Industry; Health Industry; Health Industry; Health Industry; United States
Hamermesh, Richard G., Joseph B. Fuller, and Matthew Preble. "GenapSys: Business Models for the Genome." Harvard Business School Case 814-050, January 2014. (Revised December 2014.)
- Article
The Economic Consequences of Hospital Admissions
By: Carlos Dobkin, Amy Finkelstein, Raymond Kluender and Matthew Notowidigdo
We use an event study approach to examine the economic consequences of hospital admissions for adults in two datasets: survey data from the Health and Retirement Study, and hospitalization data linked to credit reports. For non-elderly adults with health insurance,... View Details
Keywords: Personal Finance; Borrowing and Debt; Insurance; Insolvency and Bankruptcy; Health Care and Treatment
Dobkin, Carlos, Amy Finkelstein, Raymond Kluender, and Matthew Notowidigdo. "The Economic Consequences of Hospital Admissions." American Economic Review 108, no. 2 (February 2018): 308–352.
- 27 Jul 2011
- Research & Ideas
Customer Loyalty Programs That Work
ExtraCare, and pay-for-membership cards for stores including Costco. In a very basic form loyalty schemes have been around for as long as people have been exchanging goods—consider the farmer who threw in an... View Details
- 02 Jul 2013
- First Look
First Look: July 2
political system, our review of the literature finds no academic consensus on the consequences of inequality for the health of the economy or the democracy, or for nearly any other macro-level outcome. With the academic community reaching... View Details
Keywords: Anna Secino
- 02 Sep 2014
- First Look
First Look: September 2
legacy labor and health care costs-is seriously incomplete and that GM's share collapsed for many of the same reasons that many of the other... View Details
Keywords: Sean Silverthorne
- September 2013
- Article
Testimonials Do Not Convert Patients from Brand to Generic Medication
By: John Beshears, James J. Choi, David Laibson, Brigitte C. Madrian and Gwendolyn Reynolds
Objectives: To assess whether the addition of a peer testimonial to an informational mailing increases conversion rates from brand name prescription medications to lower-cost therapeutic equivalents, and whether the testimonial's efficacy increases when... View Details
Keywords: Testimonial; Peer Information; Social Proximity; Communication; Generic Medication; Familiarity; Marketing Communications; Decision Choices and Conditions; Identity; Health Care and Treatment; Marketing Reference Programs; Power and Influence; Brands and Branding; Health Industry
Beshears, John, James J. Choi, David Laibson, Brigitte C. Madrian, and Gwendolyn Reynolds. "Testimonials Do Not Convert Patients from Brand to Generic Medication." American Journal of Managed Care 19, no. 9 (September 2013): e314–e316.
- July 2014
- Case
BMVSS: Changing Lives through Innovation One Jaipur Limb at a Time (Abridged)
By: Srikant Datar, Saloni Chaturvedi and Caitlin Bowler
Bhagwan Mahaveer Viklang Sahayata Samiti (BMVSS) is an Indian not-for-profit organization engaged in assisting differently-abled persons by providing them with the legendary low-cost prosthesis, the Jaipur Foot, and other mobility-assisting devices, free of cost. Known... View Details
Keywords: Nonprofit Organizations; Financial Condition; Health Care and Treatment; Diversity; Growth and Development Strategy; Philanthropy and Charitable Giving; Medical Devices and Supplies Industry; Medical Devices and Supplies Industry; India
Datar, Srikant, Saloni Chaturvedi, and Caitlin Bowler. "BMVSS: Changing Lives through Innovation One Jaipur Limb at a Time (Abridged)." Harvard Business School Case 115-009, July 2014.
- 25 Jun 2013
- First Look
First Look: June 25
Publications 2006 pub Leviathan Evolving: New Varieties of State Capitalism in Brazil and Beyond By: Musacchio, Aldo, and Sergio G. Lazzarini Abstract—In this book we describe the transformation of state... View Details
Keywords: Anna Secino
- 28 Feb 2017
- First Look
First Look at New Research, February 28
case:https://cb.hbsp.harvard.edu/cbmp/product/116058-PDF-ENG Harvard Business School Case 817-048 Augmedix In April 2015, Ian Shakil and Pelu Tran, cofounders of Augmedix, are discussing how to grow their emerging View Details
Keywords: Sean Silverthorne
- 15 Mar 2024
- HBS Case
Let's Talk: Why It's Time to Stop Avoiding Taboo Topics at Work
could say: “I realize this is a tough month, but the sooner the better. I will schedule a time to discuss this with you next month.” Ask for a meeting with at least 24 hours’ notice. Set a clear agenda when you request the meeting and... View Details
Keywords: by Avery Forman